@Bgall and @49parkn, I am not disputing this is a great company. I concur with those sentiments.
The company is on track to make ~$10m EBIT (from $100m gross revenue) this year but has been trading at a valuation of over $500m. A 50x multiple is a little bit excessive for a business of this nature.
It seems more likely that a 10-15x EBITDA multiple would be more appropriate which is consistent with high growth healthcare/ medtech enterprises.
I think it would be naive of us to not expect Ben and Matua to sell down 30% or more of their stock to realise some gains.
IMHO GLTA DYOR
- Forums
- ASX - By Stock
- Bell Potter Ratings
@Bgall and @49parkn, I am not disputing this is a great company....
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.6¢ |
Change
0.001(0.53%) |
Mkt cap ! $54.70M |
Open | High | Low | Value | Volume |
10.5¢ | 11.0¢ | 9.1¢ | $87.66K | 880.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2314 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 10505 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2245 | 0.094 |
1 | 53230 | 0.091 |
3 | 63222 | 0.090 |
1 | 50 | 0.085 |
1 | 6300 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 10505 | 2 |
0.097 | 47189 | 1 |
0.100 | 33707 | 1 |
0.105 | 50000 | 1 |
0.110 | 129976 | 4 |
Last trade - 13.58pm 06/06/2024 (20 minute delay) ? |
|
|||||
Last
9.4¢ |
  |
Change
0.001 ( 1.08 %) |
|||
Open | High | Low | Volume | ||
10.5¢ | 11.0¢ | 9.2¢ | 169156 | ||
Last updated 14.03pm 06/06/2024 ? |
Featured News
VIT (ASX) Chart |